Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Uploaded on Aug 12, 2010
Sagar Lonial, MD, an oncologist at Winship Cancer Institute, Emory University, treats people with multiple myeloma. Although the prognosis for people with this cancer is poor, progress is being made. Twenty years ago, the survival rate was two to three years, it's now four to five. One of the keys to some patients' longevity, says Lonial, is increasing enrollment in clinical trials and access to life-extending drugs.